BioRem Statistics

Total Valuation

BioRem has a market cap or net worth of CAD 40.11 million. The enterprise value is 34.85 million.

Market Cap	40.11M
Enterprise Value	34.85M

Important Dates

The last earnings date was Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

BioRem has 15.98 million shares outstanding. The number of shares has decreased by -3.61% in one year.

Current Share Class	15.98M
Shares Outstanding	15.98M
Shares Change (YoY)	-3.61%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	2.02%
Owned by Institutions (%)	n/a
Float	15.66M

Valuation Ratios

The trailing PE ratio is 25.41 and the forward PE ratio is 9.65.

PE Ratio	25.41
Forward PE	9.65
PS Ratio	1.16
PB Ratio	3.29
P/TBV Ratio	3.29
P/FCF Ratio	18.02
P/OCF Ratio	15.61
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.54, with an EV/FCF ratio of 15.66.

EV / Earnings	16.51
EV / Sales	1.00
EV / EBITDA	9.54
EV / EBIT	11.11
EV / FCF	15.66

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.25.

Current Ratio	1.89
Quick Ratio	1.56
Debt / Equity	0.25
Debt / EBITDA	0.84
Debt / FCF	1.39
Interest Coverage	18.58

Financial Efficiency

Return on equity (ROE) is 19.05% and return on invested capital (ROIC) is 13.53%.

Return on Equity (ROE)	19.05%
Return on Assets (ROA)	7.52%
Return on Invested Capital (ROIC)	13.53%
Return on Capital Employed (ROCE)	21.47%
Revenue Per Employee	1.02M
Profits Per Employee	62,064
Employee Count	34
Asset Turnover	1.33
Inventory Turnover	10.47

Taxes

In the past 12 months, BioRem has paid 768,169 in taxes.

Income Tax	768,169
Effective Tax Rate	26.69%

Stock Price Statistics

The stock price has decreased by -12.97% in the last 52 weeks. The beta is 0.59, so BioRem's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-12.97%
50-Day Moving Average	2.17
200-Day Moving Average	2.16
Relative Strength Index (RSI)	60.95
Average Volume (20 Days)	45,808

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioRem had revenue of CAD 34.73 million and earned 2.11 million in profits. Earnings per share was 0.10.

Revenue	34.73M
Gross Profit	8.42M
Operating Income	3.14M
Pretax Income	2.88M
Net Income	2.11M
EBITDA	3.46M
EBIT	3.14M
Earnings Per Share (EPS)	0.10

Full Income Statement

Balance Sheet

The company has 8.35 million in cash and 3.08 million in debt, giving a net cash position of 5.27 million or 0.33 per share.

Cash & Cash Equivalents	8.35M
Total Debt	3.08M
Net Cash	5.27M
Net Cash Per Share	0.33
Equity (Book Value)	12.20M
Book Value Per Share	0.76
Working Capital	11.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.57 million and capital expenditures -344,798, giving a free cash flow of 2.23 million.

Operating Cash Flow	2.57M
Capital Expenditures	-344,798
Free Cash Flow	2.23M
FCF Per Share	0.14

Full Cash Flow Statement

Margins

Gross margin is 24.25%, with operating and profit margins of 9.03% and 6.08%.

Gross Margin	24.25%
Operating Margin	9.03%
Pretax Margin	8.29%
Profit Margin	6.08%
EBITDA Margin	9.96%
EBIT Margin	9.03%
FCF Margin	6.41%

Dividends & Yields

BioRem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.61%
Shareholder Yield	3.61%
Earnings Yield	5.26%
FCF Yield	5.55%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioRem has an Altman Z-Score of 3.77 and a Piotroski F-Score of 5.

Altman Z-Score	3.77
Piotroski F-Score	5